Active case finding of tuberculosis in Europe: A Tuberculosis Network European Trials Group (TBNET) survey

European Respiratory Journal

Volumn 32, Issue 4, 2008, Pages 1023-1030

  Bothamley, G H ^a   Ditiu, L ^b   Migliori, G B ^b   Lange, C ^c   Hafizi, H ^d   Mezhlumyan, N ^d   Mamedova, S ^d   Wanlin, M ^d   Zutic, H ^d   Stefanova, D ^d   Simunovic, A ^d   Hadjianastassiou, C ^d   Falzon, D ^d   Salakaia, A ^d   Georgia, S ^d   Blondal T ^d   Chemtob, D ^d   Khasanovna, B K ^d   Elmira, A ^d   Leimans, J ^d   Davidaviciene, E ^d   Vidoevska, A ^d   Asciak, A P ^d   Bojovic, O ^d   Winje, B A ^d   Korzeniewska, M ^d   Solovic, I ^d   Erzen, D ^d   Saidaliev, S ^d   Khaldurdyevna, D M ^d   Sakalska, O ^d   Djumabaevna, U D ^d   Schmidgruber, B ^d   Kalechitz, O M ^d   Vankersshaever, G ^d   Kos, S ^d   Ravn, P ^d   Kliiman, K ^d   Ruohonen, R ^d   Mallet, H P ^d   Bock Hensley, O ^d   Loytzved, G ^d   Somoskovi A ^d   Horvath, I ^d   Keane, J ^d   Codecasa, L R ^d   Chaussade, F ^d   Soltan, V ^d   Arend, S ^d   Villar, M ^d   Husar, I ^d   Stoicescu, P ^d   Rybka, L ^d   Pesut, D ^d   Garcia, J M ^d   Bruchfeld, J ^d   Julander, I ^d   Janssens, J P ^d   Ergonul, O ^d   more..

^a HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c RESEARCH CENTER BORSTEL   (Germany)

^d Research Center Borstel ^*

Author keywords

Active case finding; Contacts; Europe; Screening; Tuberculosis

Indexed keywords

GAMMA INTERFERON; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ARTICLE; CASE FINDING; CLINICAL FEATURE; COUGHING; CYTOKINE PRODUCTION; DRUG UPTAKE; EUROPE; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMIGRANT; INTERNATIONAL COOPERATION; MAJOR CLINICAL STUDY; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRISONER; PROTEIN DETERMINATION; QUESTIONNAIRE; SCREENING TEST; SPUTUM EXAMINATION; THORAX RADIOGRAPHY; TREATMENT DURATION; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL; WORLD HEALTH ORGANIZATION;

ANTITUBERCULAR AGENTS; CLINICAL TRIALS AS TOPIC; EUROPE; HIV INFECTIONS; HUMANS; MASS SCREENING; MYCOBACTERIUM TUBERCULOSIS; QUESTIONNAIRES; TUBERCULIN TEST; TUBERCULOSIS;

EID: 58149251629     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00011708     Document Type: Article

References (56)

1. World Health Organization. Global tuberculosis control: surveillance, planning, financing. Geneva, World Health Organization, 2007.
2. Hopewell PC, Pai M, Maher D, Uplekar M, Raviglione MC. International standards for tuberculosis care. Lancet Infect Dis 2006; 6: 710-725.
3. Migliori GB, Hopewell PC, Blasi F, Spanevello A, Raviglione MC. Improving the TB case management: the International Standards for Tuberculosis Care. Eur Respir J 2006; 28: 687-690.
4. Broekmans JF, Migliori GB, Rieder HL, et al. European framework for tuberculosis control and elimination in countries with low incidence. Recommendations of the World Health Organization (WHO) International Union against Tuberculosis and Lung Disease (IUATLD) and the Royal Netherlands Tuberculosis Association (KNCV) Working Group. Eur Respir J 2002; 19: 765-775.
5. Coker R, Bell A, Pitman R, et al. Tuberculosis screening in migrants in selected European countries shows wide disparities. Eur Respir J 2006; 27: 801-807.
6. American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000; 161: 1376-1395.
7. Clancy L, Rieder HL, Enarson DA, Spinaci S. Tuberculosis elimination in the countries of Europe and other industrialized countries. Eur Respir J 1991; 4: 1288-1295.
8. Surveillance of tuberculosis in Europe EuroTB. www.euroTB.org Stockholm/Geneva, European Centre for Disease Prevention and Control/World Health Organization European region.
9. Meijer J, Barnett GD, Kubik A, Styblo K. Identification of sources of infection. Bull Int Union Tuberc 1971; 45: 5-54.
10. Aluoch JA, Swai OB, Edwards EA, et al. Study of case-finding for pulmonary tuberculosis in outpatients complaining of chronic cough at a district hospital in Kenya. Am Rev Respir Dis 1984; 129: 915-920.
11. Golub JE, Mohan CI, Comstock GW, Chaisson RE. Active case finding of tuberculosis: historical perspective and future prospects. Int J Tuberc Lung Dis 2005; 9: 1183-1203.
12. Liippo KK, Kumala K, Tala EO. Focusing tuberculosis contact tracing by smear grading of index cases. Am Rev Respir Dis 1993; 148: 235-236.
13. National Collaborating Centre for Chronic Conditions. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London, Royal College of Physicians, 2006.
14. Becerra MC, Pachao-Torreblanca IF, Bayona J, et al. Expanding tuberculosis case detection by screening household contacts. Public Health Report 2005; 120: 271-277.
15. Irish C, Jolly E, Baker T. Contact tracing smear-positive and non-pulmonary tuberculosis in a high incidence area. Thorax 1997; 52: A34.
16. Ormerod LP. Results of tuberculosis contact tracing: Blackburn 1982-1990. Resp Med 1993; 87: 127-131.
17. Kumar S, Innes JA, Skinner C. Yield from tuberculosis contact tracing in Birmingham. Thorax 1992; 47: 875.
18. Van Deutekom H, Hoijng SP, de Haas PE, Langendam MW. Clustered tuberculosis cases: do they represent recent transmission and can they be detected earlier? Am J Resp Crit Care Med 2004; 169: 806-810.
19. Solsona J, Cayla JA, Verdu E, et al. Molecular and conventional epidemiology of tuberculosis in an inner city district. Int J Tuberc Lung Dis 2001; 5: 1159-1163.
20. Rose C, Zerbe G, Lantz S, Bailey W. Establishing priority during investigation of tuberculosis contacts. Am Rev Respir Dis 1979; 119: 603-609.
21. Migliori GB, Khomenko AG, Punga VV, et al. Cost-effectiveness analysis of tuberculosis control policies in Ivanovo Oblast, Russian Federation. Ivanovo Tuberculosis Project Study Group. Bull World Health Organ 1998; 76: 475-483.
22. Murray CJ, Salomon JA. Modeling the impact of global tuberculosis control strategies. Proc Natl Acad Sci USA 1998; 95: 13881-13886.
23. Currie CS, Williams BG, Cheng R, Dye C. Tuberculosis epidemics driven by HIV: is prevention better than cure? AIDS 2003; 17: 2501-2508.
24. Joint Tuberculosis Committee of the British Thoracic Society. Control and prevention of tuberculosis in the United Kingdom: Code of Practice 2000. Thorax 2000; 55: 887-901.
25. Whalen CC, Johnson JL, Okwera A, et al. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration. N Engl J Med 1997; 337: 801-808.
26. Elzi L, Schlegel M, Weber R, et al. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission. Clin Infect Dis 2007; 44: 94-102.
27. Luetkemayer AF, Charlebois ED, Flores LL, et al. Comparison of an interferon-c release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med 2007; 175: 737-742.
28. Aerts A, Hauer B, Wanlin M, Veen J. Tuberculosis and tuberculosis control in European prisons. Int J Tuberc Lung Dis 2006; 10: 1215-1223.
29. Drobniewski FA, Balabanova YM, Ruddy MC, et al. Tuberculosis, HIV seroprevalence and intravenous drug abuse in prisoners. Eur Respir J 2005; 26: 298-304.
30. March JC, Oviedo-Joekes E, Romero M. Factors associated with reported hepatitis C and HIV among injecting drug users in ten European cities. Enferm Infect Microbiol Clin 2007; 25: 91-97.
31. Fleming MF, Krupitsky E, Tsoy M, et al. Alcohol and drug use disorders, HIV status and drug resistance in a sample of Russian TB patients. Int J Tuberc Lung Dis 2006; 10: 565-570.
32. Pesut D. Active case detection for tuberculosis in risk groups in Serbia. Med Pregl 2004; 57: Suppl. 1, 75-80.
33. Judson FN, Sbarbaro JA, Tapy JM, Cohn DL. Tuberculosis screening: evaluation of a food handlers' program. Chest 1983; 83: 879-882.
34. Dasgupta K, Menzies D. Cost-effectiveness of tuberculosis control strategies among immigrants and refugees. Eur Respir J 2005; 25: 1107-1116.
35. Van den Brande P, Uydebrouck M, Vermeire P, Demedts M, the VGRT (Flemish Lung and Tuberculosis Association). Tuberculosis in asylum seekers in Belgium. Eur Respir J 1997; 10: 610-614.
36. Chemtob D, Leventhal A, Weiler-Ravell D. Screening and management of tuberculosis in immigrants: the challenge beyond professional competence. Int J Tuberc Lung Dis 2003; 7: 959-966.
37. French CE, Antoine D, Gelb D, Jones JA, Gilbert RL, Watson JM. Tuberculosis in non-UK-born persons, England and Wales, 2001-2003. Int J Tuberc Lung Dis 2007; 11: 577-584.
38. Lillebaek T, Andersen AB, Dirksen A, Smith E, Skovgaard LT, Kok-Jensen A. Persistent high incidence of tuberculosis in immigrants in a low-incidence country. Emerg Infect Dis 2002; 8: 679-684.
39. Verver S, Bwire R, Borgdorff MW. Screening for pulmonary tuberculosis among immigrants: estimated effect on severity of disease and duration of infectiousness. Int J Tuberc Lung Dis 2001; 5: 419-425.
40. Verver S, van Soolingen D, Borgdorff MW. Effect of screening of immigrants on tuberculosis transmission. Int J Tuberc Lung Dis 2002; 6: 121-129.
41. Falzon D, Infuso A, Aït-Belghiti F. In the European Union, TB patients from former Soviet countries have a high risk of multidrug resistance. Int J Tuberc Lung Dis 2006; 10: 954-958.
42. Matteelli A, Migliori GB, Cirillo D, Centis R, Girardi E, Raviglione MC. Multidrug-resistant and extensively drugresistant Mycobacterium tuberculosis: epidemiology and control. Expert Rev Anti Infect Ther 2007; 5: 857-871.
43. Migliori GB, Loddenkemper R, Blasi F, Raviglione MC. 125 years after Robert Koch's discovery of the tubercle bacillus the new XDR-TB threat. Is "science" enough to tackle the epidemic? Eur Respir J 2007; 29: 423-427.
44. Bothamley GH, Rowan JP, Griffiths CJ, et al. Screening for tuberculosis: the port of arrival scheme compared with screening in general practice and the homeless. Thorax 2002; 57: 45-49.
45. Carvalho AC, Saleri N, El-Hamad I, et al. Completion of screening for latent tuberculosis infection among immigrants. Epidemiol Infect 2005; 133: 179-185.
46. Sanchez MA, Blower SM. Uncertainty and sensitivity analysis of the basic reproductive rate: tuberculosis as an example. Am J Epidemiol 1997; 145: 1127-1137.
47. Rennie TW, Bothamley GH, Engova D, Bates IP. Patient choice promotes adherence in preventive treatment for tuberculosis. Eur Respir J 2007; 30: 728-735.
48. Berkel GM, Cobelens FG, de Vries G, Draayer-Jansen IW, Borgdorff MW. Tuberculin skin test: estimation of positive and negative predictive values from routine data. Int J Tuberc Lung Dis 2005; 9: 310-316.
49. Moran-Mendoza O, Marion SA, Elwood K, Patrick DM, Fitzgerald JM. Tuberculin skin test size and risk of tuberculosis development: a large population-based study in contacts. Int J Tuberc Lung Dis 2007; 11: 1014-1020.
50. Cobelens FG, Egwaga SM, van Ginkel T, Muwinge H, Matee MI, Borgdorff MW. Tuberculin skin testing in patients with HIV infection: limited benefit of reduced cutoff values. Clin Infect Dis 2006; 43: 634-639.
51. Wang L, Tuner MO, Elwood RK, Schulzer M, Fitzgerald JM. A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax 2002; 57: 804-809.
52. Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole-blood IFN-γ assay for the development of active TB disease. Am J Respir Crit Care Med 2008; 177: 1164-1170.
53. Smieja MJ, Marchetti CA, Cook DJ, Snaill FM. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev 2000; 2: CD001363.
54. Ewer K, Millington KA, Deeks JJ, Alvarez L, Bryant G, Lalvani A. Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med 2006; 174: 831-839.
55. Horsburgh CR. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 2004; 350: 2060-2067.
56. Demers C, McMurray JJ, Swedberg K, et al. Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure. JAMA 2005; 294: 1794-1798.